GENE ONLINE|News &
Opinion
Blog

Multiomics
Feature JPM
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
Funding Multiomics
Freenome Raises $300 Million Series D for Cancer-Detecting Multiomics Platform
2021-12-08
Microfluidics
Sequanta Partners with Surging Single-Cell Genomics Startup to Serve Multi-Omics Market in China
2021-07-11
Interviews Precision Oncology
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
In-Depth Precision Oncology
Precision Oncology: Overview of Diagnostic Technologies
2021-05-25
Multiomics
ROSALIND Partners with Two Korean Biotechs to Expand Cancer Research in Asia
2021-04-16
Funding Cancer Screening
Freenome Receives $270 Million Funding for Early Cancer Detection
2020-08-27
LATEST
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
2025-01-17
ZYN Nicotine Pouches Receive FDA Marketing Authorization
2025-01-17
Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report
2025-01-16
2025 Starts with a Jolt: Layoffs Hit the Life Sciences Industry Ahead of JPM
2025-01-16
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
Pre-JPM 2025: The Quiet Deals You May Have Missed Before the Big Show
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
READ MORE
EVENT
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top